Clinical Trial Update: CBM588 in Improving Clinical Outcomes in Patients Who Have Undergone Donor Hematopoietic Stem Cell Transplant [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating CBM588 to improve outcomes in patients who have undergone donor hematopoietic stem cell transplantation; the study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematopoietic and Lymphoid Cell Neoplasm

Drugs mentioned

• CBM588

Snippet

Sponsor: City of Hope Medical Center | Conditions: Hematopoietic and Lymphoid Cell Neoplasm | Phase 1 | Status: ACTIVE_NOT_RECRUITING